Vanguard Asset Management’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
Other funds holding AMLX
SVCM
Vanguard Asset Management's AMLX Position: Q3 2026 in Review
Vanguard Asset Management increased its Amylyx Pharmaceuticals (AMLX) stake by 14% in Q3 2026, buying an estimated $213K and bringing the position to 64,982 shares worth $1.89M. The position accounts for ﹤0.01% of the portfolio, ranked #1577.
Vanguard Asset Management first reported a position in AMLX in Q1 2026 and has held it in 3 quarters since. 230 funds tracked by Wall St. Rank hold AMLX as of Q3 2026.
- Vanguard Asset Management held 64,982 shares of Amylyx Pharmaceuticals worth $1.89M as of Q3 2026.
- Vanguard Asset Management bought 8,034 Amylyx Pharmaceuticals shares in Q3 2026, an estimated $213K.
- Amylyx Pharmaceuticals made up ﹤0.01% of Vanguard Asset Management's portfolio in Q3 2026, its #1577 holding.
- Vanguard Asset Management first reported a position in Amylyx Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
- 230 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q3 2026.
Based on Vanguard Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.